Your browser doesn't support javascript.
Covid-19 in kidney transplant recipients.
Vnitr Lek ; 68(7): 444-448, 2022.
Article in English | MEDLINE | ID: covidwho-2114787
ABSTRACT
Kidney transplant recipients are a very vulnerable population at risk of severe course and death from Covid-19. Several antiviral drugs are now available for the treatment of nonhospitalized individuals with mild to moderate Covid-19 and hospitalized patients with severe disease. The combination of monoclonal antibodies is also available to be used as pre-exposure prophylaxis in elderly patients. Previously used monoclonal antibodies for post-exposure prophylaxis are no longer effective because of the new mutations and are no longer recommended. Although the immune response to Covid-19 vaccines is impaired in kidney transplant recipients, the effectiveness of the Covid-19 vaccines was described even in this immunocompromised group. Therefore vaccination, together with anti-epidemic measures, remains the most important tool to prevent Covid-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Aged / Humans Language: English Journal: Vnitr Lek Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Aged / Humans Language: English Journal: Vnitr Lek Year: 2022 Document Type: Article